Figure 4From: High-resolution motion compensated MRA in patients with congenital heart disease using extracellular contrast agent at 3 TeslaIntraobserver method agreement of FP-MRA- (A) and HR-MRA-measurements (B) of reviewer 1. Interobserver method agreement derived from FP-MRA (C) and HR-MRA (D) measurements of reviewers 1 and 2.Back to article page